Having trouble viewing this email? View in your browser.
Weekly News
14 September 2021

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.

TAE Steering Committee Elections 2021!

In 2021 we are looking for two TAE Steering Committee (TAE SC) members, one member with a background in Clinical Microbiology (CM) and one with a background in Infectious Diseases (ID). The resulting vacancies for a three-year term (April 2022 - April 2025) is to be filled with two new members. The call for candidates is open now, and closes on Thursday, 7 ­October 2021 at 12:00 noon CEST. Eligible ESCMID Young Scientist Members are encouraged to send their application via the link below as soon as possible.

Public Consultation Phase open for new ESCMID Guidelines

"ESCMID COVID-19 Living Guidelines: Drug treatment and clinical management" is undergoing public consultation. Check here to participate. The deadline to provide feedback and comments is 07 October 2021.

IDWeek Presents: 24 Hours of COVID -19 - Chasing the Sun

ESCMID is very proud to participate in the IDWeek event Chasing the Sun: COVID-19, Beyond the Horizon. This global event will begin on Wednesday, September 29 and conclude on Thursday, Sept. 30 2021.

ESCMID Summer School 2021 – A resounding success!

The 19th ESCMID Summer School successfully took place in Carcavelos, Portugal from 4-11 September 2021, with 48 young professionals from across the field of infection coming together for the first onsite ESCMID event.

The 20th ESCMID Summer School will take place in Rome, Italy from 2–9 July, 2022.

EMA communication: "Human Medicines Highlights" Newsletter - September 2021 issue

ESCMID is pleased to share with you the latest edition of the EMA monthly Newsletter which includes important decisions by the EMA Scientific Committees and updates on medicines safety. We hope that you will find this useful. You can access the Newsletter by clicking here.

Shortening antibiotic course for treating bloodstream infections by Enterobacterales

The authors aimed to prove that 7-day courses of antibiotics for eBSI, allow to reduce antibiotic exposure of patients, while achieving similar clinical outcomes compared to 14-day schemes. Their data suggests that this is possible in many cases, reducing antibiotic exposure.